Free Trial

BriaCell Therapeutics (BCTXW) Competitors

BriaCell Therapeutics logo
$0.03 0.00 (-9.14%)
As of 08/5/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BCTXW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, CELUW, and CINGW

Should you be buying BriaCell Therapeutics stock or one of its competitors? The main competitors of BriaCell Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "pharmaceutical products" industry.

BriaCell Therapeutics vs. Its Competitors

BriaCell Therapeutics (NASDAQ:BCTXW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings.

In the previous week, BriaCell Therapeutics and BriaCell Therapeutics both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 0.95 beat BriaCell Therapeutics' score of -0.18 indicating that 180 Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
BriaCell Therapeutics Neutral
180 Life Sciences Positive

Company Net Margins Return on Equity Return on Assets
BriaCell TherapeuticsN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BriaCell TherapeuticsN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

180 Life Sciences beats BriaCell Therapeutics on 1 of the 1 factors compared between the two stocks.

Get BriaCell Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCTXW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BCTXW vs. The Competition

MetricBriaCell TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$137.09M$5.59B$9.53B
Dividend YieldN/A3.74%4.71%4.14%
P/E RatioN/A3.7428.8923.88
Price / SalesN/A4,281.35447.6498.82
Price / CashN/A13.1935.6858.35
Price / BookN/A39.208.165.60
Net IncomeN/A-$90.99M$3.25B$265.26M
7 Day PerformanceN/A-0.96%1.12%-0.15%
1 Month PerformanceN/A4.00%8.22%6.07%
1 Year PerformanceN/A178.37%29.12%24.21%

BriaCell Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BCTXW
BriaCell Therapeutics
N/A$0.03
-12.0%
N/A-79.9%$0.00N/A0.008Short Interest ↑
Gap Down
ATNFW
180 Life Sciences
N/A$0.01
-0.9%
N/A+38.2%$0.00N/A0.007
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
+84.9%
N/A-74.2%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.11
-8.3%
N/A+57.3%$0.00$106.21K0.0040Gap Up
ALVOW
Alvotech
N/A$1.60
-17.5%
N/A-41.2%$0.00$585.60M0.004Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
+2.9%
N/A-24.8%$0.00N/A0.0015Gap Up
BFRIW
Biofrontera
N/A$0.15
-2.6%
N/A+214.7%$0.00$38.00M0.0070Gap Down
BTMDW
biote
N/A$0.02
+19.3%
N/A-99.0%$0.00$199.38M0.00N/AGap Up
CELUW
Celularity
N/A$0.05
-10.0%
N/A+143.9%$0.00$54.22M0.00220Positive News
Gap Down
CINGW
Cingulate
N/A$0.12
-16.5%
N/A+1,285.6%$0.00N/A0.0020Gap Down

Related Companies and Tools


This page (NASDAQ:BCTXW) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners